Saulius Cicėnas - Concepedia

Author

Saulius Cicėnas

Also Known As

Cicenas Saulius, Cicenas, Saulius, S Cicenas, S Cicénas, S Cicėnas, S. Cicenas, Saulius Cicenas, Saulius Cicènas, Saulius Cicėnas

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Vilnius University National Cancer Institute Roche (Switzerland)Roche (United Kingdom)Vestre Viken Hospital Trust

About

Saulius Cicėnas is an author at Vilnius University specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.8K
2	Epidemiology	2	2	31
3	Public Health	1	1	17
4	Global Health	1	1	17
5	Health Policy	1	1	17

Saulius Cicėnas

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial Tony Mok, Yi‐Long Wu, Iveta Kudaba, The Lancet	2019	3.2K
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study Federico Cappuzzo, Tudor–Eliade Ciuleanu, Lilia Stelmakh, The Lancet Oncology Placebo-controlled Phase 3Maintenance TreatmentMedicineCancer ManagementPharmacology	2010	1.2K
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study Tudor–Eliade Ciuleanu, Lilia Stelmakh, Saulius Cicėnas, The Lancet Oncology Second-line TreatmentOncologyCancer ManagementPoor PrognosisCancer Treatment	2012	371
SATURN: A double-blind, randomized, phase III study of maintenance erlotinib versus placebo following nonprogression with first-line platinum-based chemotherapy in patients with advanced NSCLC Federico Cappuzzo, Tudor–Eliade Ciuleanu, L. Stelmakh, Journal of Clinical Oncology Advanced NsclcSaturn StudyOncologyMedicineCancer Management	2009	125
Lung cancer in patients with tuberculosis Saulius Cicėnas, Vladislavas Vencevičius World Journal of Surgical Oncology	2007	83
Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study) Inger Johanne Zwicky Eide, Åslaug Helland, Simon Ekman, Lung Cancer -Negative PatientsTumor BiologyMedicinePathologyMolecular Oncology	2020	63
Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study) Saulius Cicėnas, Sarayut Lucien Geater, Petar Petrov, Lung Cancer	2016	57
Spontaneous pneumothorax as a first sign of pulmonary carcinoma Vladislavas Vencevičius, Saulius Cicėnas World Journal of Surgical Oncology	2009	36
The value of MMP-9 for breast and non-small cell lung cancer patients' survival Diana Schveigert, Saulius Cicėnas, S. Bruz̆as, Advances in Medical Sciences Breast OncologyCancer RiskMedicineCancer ManagementPathology	2013	29
Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania Rūta Everatt, Irena Kuzmickienė, Edita Davidavičienė, The International Journal of Tuberculosis and Lung Disease	2016	29

Page 1